Close Menu

NEW YORK – Biocept reported after the close of the market on Wednesday that its first quarter revenues rose 41 percent year over year, driven by a 27 percent increase in revenue per commercial accession.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.